---
title: Cultivation of 3D Cell Aggregates in Perfusion
---

| Not rendering correctly? View this email as a web page here.     Culture of 3D Cell Aggregates in Perfusion       Research example with the Eppendorf DASbox® Mini Bioreactor System           Dear Reader, Three-dimensional (3D) cell aggregates are of great interest for many applications, including disease modeling, drug toxicity assessment, and manufacture of stem cell-based products. Stirred-tank bioreactors are promising culture systems for 3D cell aggregates, as they allow efficient establishment and maintenance of cell aggregates, process monitoring and control, and process scale-up to larger volumes. Furthermore, they can be operated in perfusion mode, which allows 3D cell aggregates to be sustained longer than in traditional batch cultures.                   Researchers at the Instituto de Biologia Experimental e Tecnológica (iBET) in Portugal have tested the suitability of the Eppendorf DASbox Mini Bioreactor System for the cultivation of the human tumor cell line H157 as 3D cell aggregates. Download the application note and learn about the challenges and benefits of perfusion cultivation for stem cells and 3D cell models.         Download PDF             Eppendorf AG Bioprocess Center Rudolf-Schulten-Str. 5 52428 Juelich Germany Tel: +49 (0) 2461 980 420 Fax: +49 (0) 2461 980 499 bioprocess-info@eppendorf.de www.eppendorf.com   Local Court Hamburg HRB 76249 Turnover tax identification number pursuant to § 27 a Turnover Tax Law: DE 118649726 Chairman of the Supervisory Board: Philipp von Loeper Management Board: Thomas Bachmann (President), Detmar Ammermann (Vice Chairman), Eva van Pelt, Dr. Wilhelm Plüster         > Contact > Legal disclaimer > Privacy Statement       ©2018 Eppendorf AG       BioProcess International   2 International Place  Suite 2610  Boston,  MA   02110-2601    You received this email because you are subscribed to BPI Partner Announcements from BioProcess International. Update your email preferences to choose the types of emails you receive.  Unsubscribe from all future emails  |
| --- |